Home > Insider Trading > Filing (0001237899-14-000070)

Filing Details

Accession Number:: 0001237899-14-000070
Form Type:: 4
Zero Holdings:: No
Publication Time:: 2014-10-27 16:17:37
Reporting Period:: 2014-10-23

Filing Date:: 2014-10-27
Accepted Time:: 2014-10-27 16:17:37
SEC Url:: Form 4 Filing

Issuer

Cik	Name	Symbol	Sector (SIC)	IRS No
872589	Regeneron Pharmaceuticals Inc	REGN	Pharmaceutical Preparations (2834)	133444607

Insiders

Cik	Name	Reported Address	Insider Title	Director	Officer	Large Shareholder	Other
1226435	A Murray Goldberg	777 Old Saw Mill River Road Tarrytown NY 10591	Svp Administration & Asst Secr	No	Yes	No	No

Reported Non-Derivative Transactions

Show Other Fields >>

Sec. Name	Acquisiton - Disposition	Date	Amount	Price	Remaning Holdings	Equity Swap Involved	Form Type	Code	Nature of Ownership
Common Stock	Acquisiton	2014-10-23	60,000	$30.63	123,102	No	4	M	Direct
Common Stock	Disposition	2014-10-23	4,689	$391.93	118,413	No	4	F	Direct
Common Stock	Disposition	2014-10-23	28,523	$391.93	89,890	No	4	F	Direct
Common Stock	Disposition	2014-10-24	200	$395.96	89,690	No	4	S	Direct
Common Stock	Disposition	2014-10-24	775	$396.80	88,915	No	4	S	Direct
Common Stock	Disposition	2014-10-24	1,700	$397.65	87,215	No	4	S	Direct
Common Stock	Disposition	2014-10-24	2,100	$398.58	85,115	No	4	S	Direct
Common Stock	Disposition	2014-10-24	3,200	$399.37	81,915	No	4	S	Direct
Common Stock	Disposition	2014-10-24	7,531	$400.51	74,384	No	4	S	Direct
Common Stock	Disposition	2014-10-24	5,293	$401.51	69,091	No	4	S	Direct
Common Stock	Disposition	2014-10-24	2,500	$402.54	66,591	No	4	S	Direct
Common Stock	Disposition	2014-10-24	2,454	$403.50	64,137	No	4	S	Direct
Common Stock	Disposition	2014-10-24	1,035	$404.18	63,102	No	4	S	Direct

Equity Swap Involved	Form Type	Code	Nature of Ownership
No	4	M	Direct
No	4	F	Direct
No	4	F	Direct
No	4	S	Direct
No	4	S	Direct
No	4	S	Direct
No	4	S	Direct
No	4	S	Direct
No	4	S	Direct
No	4	S	Direct
No	4	S	Direct
No	4	S	Direct
No	4	S	Direct

Reported Derivative Transactions

Show Other Fields >>

Sec. Name	Sec. Type	Acquisiton - Disposition	Date	Amount	Price	Amount - 2	Price - 2
Common Stock	Non-Qualified Stock Option (right to buy)	Disposition	2014-10-23	60,000	$0.00	60,000	$30.63

Remaning Holdings	Exercise Date	Expiration Date	Equity Swap Involved	Transaction Form Type	Transaction Code	Nature of Ownership
6,736		2020-12-14	No	4	M	Direct

Reported Non-Derivative Holdings

Sec. Name	Remaning Holdings	Nature of Ownership	Explanation
Common Stock	5,650	Indirect	By 401(k) Plan
Common Stock	750	Indirect	by Spouse

Footnotes

Disposition/acquisition made pursuant to a plan intended to comply with Rule 10b5-1(c).
Represents volume-weighted average price of sales of 775 shares of Company stock on October 24, 2014 at prices ranging from $396.28 to $396.98. Upon request by the Commission staff, the Company, or a security holder of the Company, the reporting person will provide full information regarding the number of shares sold by the reporting person on October 24, 2014 at each separate price.
Represents volume-weighted average price of sales of 1,700 shares of Company stock on October 24, 2014 at prices ranging from $397.14 to $397.93. Upon request by the Commission staff, the Company, or a security holder of the Company, the reporting person will provide full information regarding the number of shares sold by the reporting person on October 24, 2014 at each separate price.
Represents volume-weighted average price of sales of 2,100 shares of Company stock on October 24, 2014 at prices ranging from $398.03 to $398.98. Upon request by the Commission staff, the Company, or a security holder of the Company, the reporting person will provide full information regarding the number of shares sold by the reporting person on October 24, 2014 at each separate price.
Represents volume-weighted average price of sales of 3,200 shares of Company stock on October 24, 2014 at prices ranging from $399.02 to $399.99. Upon request by the Commission staff, the Company, or a security holder of the Company, the reporting person will provide full information regarding the number of shares sold by the reporting person on October 24, 2014 at each separate price.
Represents volume-weighted average price of sales of 7,531 shares of Company stock on October 24, 2014 at prices ranging from $400.10 to $400.99. Upon request by the Commission staff, the Company, or a security holder of the Company, the reporting person will provide full information regarding the number of shares sold by the reporting person on October 24, 2014 at each separate price.
Represents volume-weighted average price of sales of 5,293 shares of Company stock on October 24, 2014 at prices ranging from $401.00 to $401.96. Upon request by the Commission staff, the Company, or a security holder of the Company, the reporting person will provide full information regarding the number of shares sold by the reporting person on October 24, 2014 at each separate price.
Represents volume-weighted average price of sales of 2,500 shares of Company stock on October 24, 2014 at prices ranging from $402.00 to $402.89. Upon request by the Commission staff, the Company, or a security holder of the Company, the reporting person will provide full information regarding the number of shares sold by the reporting person on October 24, 2014 at each separate price.
Represents volume-weighted average price of sales of 2,454 shares of Company stock on October 24, 2014 at prices ranging from $403.00 to $403.99. Upon request by the Commission staff, the Company, or a security holder of the Company, the reporting person will provide full information regarding the number of shares sold by the reporting person on October 24, 2014 at each separate price.
Represents volume-weighted average price of sales of 1,035 shares of Company stock on October 24, 2014 at prices ranging from $404.00 to $404.41. Upon request by the Commission staff, the Company, or a security holder of the Company, the reporting person will provide full information regarding the number of shares sold by the reporting person on October 24, 2014 at each separate price.
The option became exercisable with respect to all shares underlying the option on December 31, 2013, based upon the satisfaction by the company of certain performance criteria during the period ended December 31, 2013.